<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">AJMB</journal-id>
			<journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
			<issn pub-type="ppub">2008-2835</issn>
			<issn pub-type="epub">2008-4625</issn>
			<publisher>
				<publisher-name>Avicenna Research Institute</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">AJMB-5-29</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Original Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Generation of a Uracil Auxotroph Strain of the Probiotic Yeast <italic>Saccharomyces boulardii</italic> as a Host for the Recombinant Protein Production</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Hamedi</surname>
						<given-names>Hassan</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Misaghi</surname>
						<given-names>Ali</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Modarressi</surname>
						<given-names>Mohammad Hossein</given-names>
					</name>
					<xref ref-type="aff" rid="AF0002">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Salehi</surname>
						<given-names>Taghi Zahraei</given-names>
					</name>
					<xref ref-type="aff" rid="AF0003">3</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Khorasanizadeh</surname>
						<given-names>Dorsa</given-names>
					</name>
					<xref ref-type="aff" rid="AF0004">4</xref>
				</contrib>
				<contrib contrib-type="author" corresp="yes">
					<name>
						<surname>Khalaj</surname>
						<given-names>Vahid</given-names>
					</name>
					<xref ref-type="aff" rid="AF0004">4</xref>
					<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
				</contrib>
			</contrib-group>
			<aff id="AF0001">
				<label>1</label>Department of Food Hygiene, Faculty of Veterinary of Medicine, University of Tehran, Tehran, Iran</aff>
			<aff id="AF0002">
				<label>2</label>Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran</aff>
			<aff id="AF0003">
				<label>3</label>Department of Microbiology, Faculty of Veterinary of Medicine, University of Tehran, Tehran, Iran</aff>
			<aff id="AF0004">
				<label>4</label>Fungal Biotechnology Group, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran</aff>
			<author-notes>
				<corresp id="cor1">
					<label>&#x002A;</label>
					<bold>Corresponding author:</bold> Vahid Khalaj, Ph.D., Fungal Biotechnology Group, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. <bold>Tel:</bold> +98 21 66480780. <bold>Fax:</bold> +98 21 66480780. <bold>E-mail:</bold>
					<email xlink:href="v_khalaj@yahoo.com">v_khalaj@yahoo.com</email>
				</corresp>
			</author-notes>
			<pub-date pub-type="ppub">
				<season>January-March</season>
				<year>2013</year>
			</pub-date>
			<volume>5</volume>
			<issue>1</issue>
			<fpage>29</fpage>
			<lpage>34</lpage>
			<history>
				<date date-type="received">
					<day>15</day>
					<month>05</month>
					<year>2012</year>
				</date>
				<date date-type="accepted">
					<day>25</day>
					<month>07</month>
					<year>2012</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright &#x00A9; 2013 Avicenna Research Institute</copyright-statement>
				<copyright-year>2013</copyright-year>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
					<p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</p>
				</license>
			</permissions>
			<abstract>
				<sec id="st1">
					<title>Background</title>
					<p>
						<italic>Saccharomyces boulardii</italic> (<italic>S. boulardii</italic>) is the best known probiotic yeast. The genetic engineering of this probiotic strain requires the availability of appropriate mutants to accept various gene constructs carrying different selection markers. As the auxotrophy selection markers are under focus, we have generated a <italic>ura3</italic> auxotroph mutant of <italic>S. boulardii</italic> for use in further genetic manipulations.</p>
				</sec>
				<sec id="st2">
					<title>Methods</title>
					<p>Classical UV mutagenesis was used for the generation of auxotroph mutants. The mutants were selected in the presence of 5-FOA (5-Fluoroorotic acid), uracil and uridine. Uracil auxotrophy phenotype was confirmed by the ability of mutants to grow in the presence of uracil and the lack of growth in the absence of this compound. To test whether the uracil auxotrophy phenotype is due to the inactivation of <italic>URA3</italic>, the mutants were transformed with a plasmid carrying the gene. An <italic>in vitro</italic> assay was used for the analysis of acid and bile resistance capacity of these mutants.</p>
				</sec>
				<sec id="st3">
					<title>Results</title>
					<p>Three mutants were found to be <italic>ura3</italic> auxotroph as they were able to grow only in the presence of uracil. When the <italic>URA3</italic> gene was added, these mutants were able to grow normally in the absence of uracil. Further <italic>in vitro</italic> analysis showed that the acid and bile resistance capacity of one of these mutants is intact and similar to the wild type.</p>
				</sec>
				<sec id="st4">
					<title>Conclusion</title>
					<p>A uracil auxotroph mutant of the probiotic yeast, <italic>S</italic>. <italic>boulardii</italic>, was generated and characterized. This auxotroph strain may have potential applications in the production and delivery of the recombinant pharmacuetics into the intestinal lumen.</p>
				</sec>
			</abstract>
			<kwd-group>
				<kwd>Probiotic</kwd>
				<kwd>Recombinant proteins</kwd>
				<kwd>Uracil</kwd>
				<kwd>Yeasts</kwd>
			</kwd-group>
		</article-meta>
	</front>
	<body>
		<sec id="S0001" sec-type="intro">
			<title>Introduction</title>
			<p>As the knowedge of probiotics expands, more possiblities arise for the engineering of the new probiotic strains. Recombinant probiotics are being considered as efficient bio-systems for the delievery of active molecules to the intestinal mucosa (<xref ref-type="bibr" rid="CIT0001">1</xref>). <italic>S. boulardii</italic> is a well known probiotic yeast which is used alone or in combination with probiotic bacteria to support digestive system (<xref ref-type="bibr" rid="CIT0002">2</xref>&#x2013;<xref ref-type="bibr" rid="CIT0006">6</xref>). <italic>S. boulardii</italic> is often marketed in a lyophilized form and is called <italic>S. boulardii lyo</italic>. The availibility of well-established genetic engineering methods in yeast has facilitated the possible genetic manipulation of this probiotic yeast.</p>
			<p>In genetic manipulation procedures, the selection of recombinant strains is usually performed by employing a suitable selection marker on a plasmid carrying the gene construct. Antibiotic resistance markers are widely used, but are considered as a major concern in probiotic applications. Hence, it is necessary to remove the antibiotic resistant gene from the host prior to commercial application (<xref ref-type="bibr" rid="CIT0007">7</xref>). In this sense, the auxtrophic markers may be a better substitute as they are indigenous (<xref ref-type="bibr" rid="CIT0008">8</xref>). Although these selection markers are commonly used in practice, but they require appropriate host strains which are auxotrophic for the specific nutrients corresponding to the inactivated gene (<xref ref-type="bibr" rid="CIT0009">9</xref>). One example of these markers is the <italic>URA3</italic> gene that encodes orotidine 5-monophosphate decarboxylase (OMPD Case), an enzyme involved in the <italic>de novo</italic> synthesis of pyrimidine ribonucleotides (<xref ref-type="bibr" rid="CIT0010">10</xref>). The inactivation of <italic>URA3</italic> results in uracil auxotrophy and 5-fluoroorotic acid resistance phenotype (<xref ref-type="bibr" rid="CIT0011">11</xref>).</p>
			<p>In the present study, a uracil auxotroph mutant of <italic>S. boulardii</italic> was generated through UV mutagenesis. The auxotroph mutant was complemented by the <italic>URA3</italic> gene. The <italic>ura3</italic>
				<sup>
					<italic>-</italic>
				</sup> mutant strain of <italic>S. boulardii</italic> can be used in future engineering of this important probiotic yeast.</p>
		</sec>
		<sec id="S0002" sec-type="materials|methods">
			<title>Materials and Methods</title>
			<sec id="S20003">
				<title>Strains, media and plasmids</title>
				<p>The yeast and bacterial strains used in the present study are listed in <xref ref-type="table" rid="T0001">Table 1</xref>. pGEM&#x2013;T Easy cloning system (Promega) was used for the cloning of PCR products. Plasmid pYES2 (Invitrogen) containing <italic>Saccharomyces cerevisiae (S. cerevisiae) URA3</italic> gene was used as a control in transformation experiments.
</p>
				<table-wrap id="T0001">
					<label>Table 1</label>
					<caption>
						<p>Strains used in this study</p>
					</caption>
					<table frame="hsides" rules="groups">
						<thead>
							<tr>
								<th align="left">Strain of <italic>S. cerevisiae</italic>
								</th>
								<th align="center">Genotype</th>
								<th align="center">Source</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td align="left">
									<bold>
										<italic>S. cerevisiae</italic> &#x3A3;1278b</bold>
								</td>
								<td align="center">Wild-type (Mat&#x3B1;)</td>
								<td align="center">Our laboratory</td>
							</tr>
							<tr>
								<td align="left">
									<italic>
										<bold>S. boulardii</bold>
									</italic>
								</td>
								<td align="center">Wild type (subspecies lyo)</td>
								<td align="center">DiarSafe, (Wren Laboratories Ltd)</td>
							</tr>
							<tr>
								<td align="left">
									<bold>
										<italic>S. boulardii</italic> M1</bold>
								</td>
								<td align="center">
									<italic>ura3</italic>
									<sup>
										<italic>-</italic>
									</sup>
								</td>
								<td align="center">This study</td>
							</tr>
							<tr>
								<td align="left">
									<bold>
										<italic>S. boulardii</italic> M2</bold>
								</td>
								<td align="center">
									<italic>ura3</italic>
									<sup>
										<italic>-</italic>
									</sup>
								</td>
								<td align="center">This study</td>
							</tr>
							<tr>
								<td align="left">
									<bold>
										<italic>S. boulardii</italic> M3</bold>
								</td>
								<td align="center">
									<italic>ura3</italic>
									<sup>
										<italic>-</italic>
									</sup>
								</td>
								<td align="center">This study</td>
							</tr>
							<tr>
								<td align="left" colspan="3">
									<bold>Strain of <italic>E. coli</italic>
									</bold>
								</td>
							</tr>
							<tr>
								<td align="left">
									<bold>
										<italic>E. coli</italic> Top10</bold>
								</td>
								<td align="center">F&#x2032;{<italic>lac</italic>Iq Tn10 (TetR)} <italic>mcr</italic>A &#x394;(<italic>mrr-hsd</italic>RMS-<italic>mcr</italic>BC) &#x3A6;80<italic>lac</italic>Z&#x394;M15 &#x394;<italic>lac</italic>X74 <italic>rec</italic>A1 <italic>ara</italic>D139 &#x394;(<italic>ara-leu</italic>)7697 <italic>gal</italic>U <italic>gal</italic>K <italic>rps</italic>L <italic>end</italic>A1 <italic>nup</italic>G</td>
								<td align="center">Invitrogen</td>
							</tr>
						</tbody>
					</table>
				</table-wrap>
				<p>Yeasts strains were grown and kept in YPD medium (1% yeast extract, 2% polypeptone and 2% dextrose). Yeast Nitrogen Base with ammonium sulphate and without amino acids (YNB medium; Sigma-Aldrich) was prepared at a concentration of 0.67% and was supplemented with 2% glucose, 10 <italic>mM</italic> uridine and uracil, and 0.1% 5-FOA (Sigma) to use in screening of auxotrophs.</p>
			</sec>
			<sec id="S20004">
				<title>DNA manipulations</title>
				<p>Genomic DNA from both <italic>S. cerevisiae</italic> &#x3A3;1278b and <italic>S. boulardii</italic> was prepared as described before (<xref ref-type="bibr" rid="CIT0012">12</xref>). All PCRs were performed as 30 cycles of 95&#x00B0;<italic>C</italic> for 1 <italic>min</italic>, 58&#x00B0;<italic>C</italic> for 30 <italic>s</italic> and 72&#x00B0;<italic>C</italic> for 1 <italic>min</italic>. The <italic>S. cerevisiae</italic> actin fragment (500 <italic>bp</italic>) was amplified using primers ACT1_F (CCCAATTGAACACGGTATTG) and ACT1_R (GCAGCGGTTTGCATTTCTTG) as a control in PCR reactions (<xref ref-type="table" rid="T0002">Table 2</xref>).
</p>
				<table-wrap id="T0002">
					<label>Table 2</label>
					<caption>
						<p>Primers used in this study</p>
					</caption>
					<table frame="hsides" rules="groups">
						<thead>
							<tr>
								<th align="left">Primer name</th>
								<th align="center">Sequence</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td align="left">
									<bold>ACT1_F (sense)</bold>
								</td>
								<td align="left">5&#x2018;CCCAATTGAACACGGTATTG3&#x2018;</td>
							</tr>
							<tr>
								<td align="left">
									<bold>ACT1_R (antisense)</bold>
								</td>
								<td align="left">5&#x2018; GCAGCGGTTTGCATTTCTTG3&#x2018;</td>
							</tr>
							<tr>
								<td align="left">
									<bold>URA3_F (sense)</bold>
								</td>
								<td align="left">5&#x2018; GTTAATGTGGCTGTGGTTTC 3&#x2018;</td>
							</tr>
							<tr>
								<td align="left">
									<bold>URA3_R (antisense)</bold>
								</td>
								<td align="left">5&#x2018;GTTACTTGGTTCTGGCGAGG3&#x2018;</td>
							</tr>
						</tbody>
					</table>
				</table-wrap>
			</sec>
			<sec id="S20005">
				<title>UV light mutagenesis and <italic>isolation of uracil auxotrophs</italic>
				</title>
				<p>A single colony from <italic>S. boulardii</italic> parental strain was grown for 20 <italic>hr</italic> in YPD broth. Cells were collected and washed with PBS and subjected to UV mutagenesis. 20 <italic>ml</italic> of cell suspension (1&#x00D7;10<sup>7</sup> viable yeasts <italic>ml</italic>
					<sup>
						<italic>&#x2212;1</italic>
					</sup> in PBS) was gently agitated by a magnetic flea in a glass petri dish (with the lid removed) 15 <italic>cm</italic> below a UV lamp (Philips, TUV 15W/ G15). A dose response experiment was carried out by removing 0.5 <italic>ml</italic> samples at 10 <italic>s</italic> intervals over a 100 <italic>s</italic> period. Irradiated cell suspensions were stored in foil-wrapped tubes at 4<italic>&#x00B0;C</italic> overnight to avoid photoreactivation. Dilutions of cell suspension from various exposure times were made and plated onto YPD agar (3 replicates per dilution). All plates were incubated in the dark at 30<italic>&#x00B0;C</italic>. Colonies were counted initially after two days and finally after four days of incubation. A kill curve was plotted to estimate the exposure time to UV light to kill 90% of cells. This was then used for the subsequent mutagenesis procedures and the UV irradiated cells were kept at 4<italic>&#x00B0;C</italic> in a foil-wrapped tube.</p>
				<p>To isolate <italic>ura3</italic> auxotroph mutants, approximately 10<sup>7</sup> mutagenized cells were spread onto 5-FOA plates containing uracil and uridine, and then were incubated at 30&#x00B0;<italic>C</italic> up to one week. The recovered colonies were isolated and plated on YNB medium with or without uracil supplement. Uracil auxotroph mutants were detected by their ability to grow only in the presence of this chemical.</p>
			</sec>
			<sec id="S20006">
				<title>Construction of URA3 cassette</title>
				<p>The <italic>S. cerevisiae URA3</italic> sequence (URA3/YEL021W, yeast genome database) was used as a template to design the <italic>URA3</italic> specific primers. The forward primer, <italic>URA3</italic>_F (5&#x2032;-G TTAATGTGGCTGTGGTT TC-3&#x2032;), and the reverse primer, <italic>URA3</italic>_R (5&#x2032;-GTTACTTGG TTC TGGCGAGG-3&#x2032;) (<xref ref-type="table" rid="T0002">Table 2</xref>), were designed to amplify an approximately 1.2 <italic>kb URA3</italic> fragment containing the entire coding sequence with 5&#x2018; and 3&#x2018; flanking regions.
</p>
				<table-wrap id="T0003">
					<label>Table 3</label>
					<caption>
						<p>Growth ability of wild type strains and <italic>ura3</italic> mutants in the presence of acid and bile</p>
					</caption>
					<table frame="border" rules="all">
						<thead>
							<tr>
								<th align="left" rowspan="2" valign="middle">Yeast strain</th>
								<th align="center" colspan="2">Growth<xref ref-type="table-fn" rid="TF0001">a</xref>
								</th>
							</tr>
							<tr>
								<th align="center">pH = 2.5<xref ref-type="table-fn" rid="TF0003">c</xref>
								</th>
								<th align="center">0.3% Oxgall</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td align="left">
									<bold>
										<italic>S. boulardii</italic> wild type</bold>
								</td>
								<td align="center">+</td>
								<td align="center">++</td>
							</tr>
							<tr>
								<td align="left">
									<bold>
										<italic>S. boulardii</italic> M1<xref ref-type="table-fn" rid="TF0002">b</xref>
									</bold>
								</td>
								<td align="center">+</td>
								<td align="center">+</td>
							</tr>
							<tr>
								<td align="left">
									<bold>
										<italic>S. boulardii</italic> M2</bold>
								</td>
								<td align="center">+</td>
								<td align="center">++</td>
							</tr>
							<tr>
								<td align="left">
									<bold>
										<italic>S. boulardii</italic> M3</bold>
								</td>
								<td align="center">&#x2013;</td>
								<td align="center">+</td>
							</tr>
							<tr>
								<td align="left">
									<bold>
										<italic>S. cerevisiae</italic> &#x3A3;1278b</bold>
								</td>
								<td align="center">&#x2013;</td>
								<td align="center">+</td>
							</tr>
						</tbody>
					</table>
					<table-wrap-foot>
						<fn id="TF0001">
							<label>A</label>
							<p>&#x2212;no growth; + growth delay&#x003E;4 <italic>hr</italic>; ++no delay in growth.</p>
						</fn>
						<fn id="TF0002">
							<label>B</label>
							<p>M1, M2 and M3:the ura3 mutant of <italic>S. boulardii</italic>
							</p>
						</fn>
						<fn id="TF0003">
							<label>C</label>
							<p>Survival after 4-<italic>hr</italic> incubation at pH=2.5</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
				<p>PCR on genomic DNA of <italic>S. boulardii</italic> was carried out using these primers. The resulting PCR fragment was cloned into pGEM-Teasy vector. The final vector was called pGEM-ura3 and used in transformation of the auxotroph strains.</p>
			</sec>
			<sec id="S20007">
				<title>Transformation of S. boulardii auxotroph strains</title>
				<p>
					<italic>S. boulardii</italic> auxotrophic yeasts (ura3<sup>-</sup>) were transformed with the plasmid pGEM-ura3 using a standard electroporation method (<xref ref-type="bibr" rid="CIT0013">13</xref>). As a positive control, a commercial episomal vector, pYES2 (Invitrogen), was used in transformation experiments. Following the transformation, cells were plated on YNB agar medium lacking uracil and uridine supplements.</p>
			</sec>
			<sec id="S20008">
				<title>Bile and acid resistance assay</title>
				<p>Resistance tests were performed as described by van der Aa K&#x00FC;hle (<xref ref-type="bibr" rid="CIT0014">14</xref>). In brief, all strains were refreshed in MYGP medium (Malt extract 1%, Yeast extract 1%, Peptone 2%, Dextrose 2%) for 24 <italic>hr</italic> at 30<italic>&#x00B0;C</italic>. Assays were performed in a 200 <italic>&#x00B5;l</italic> volume in 96-microwell plates. The wells were inoculated in triplicates with 10<sup>6</sup> yeast cells and the cells were allowed to grow for 48 <italic>hr</italic> at 30<italic>&#x00B0;C</italic> in YNB medium containing acid (pH = 2.5) or 0.3% (w/v) Oxgall (Difco). For the auxotroph mutants the medium was supplemented with uracil (10 <italic>mM</italic>). Viability tests were performed after 4 <italic>hr</italic> of incubation by plating of 100 <italic>&#x00B5;l</italic> of cell suspensions onto MYGP agar for 3 days at 30<italic>&#x00B0;C</italic>.</p>
			</sec>
		</sec>
		<sec id="S0009" sec-type="results">
			<title>Results</title>
			<sec id="S20010">
				<title>UV survival curve</title>
				<p>UV irradiation of cell suspension from <italic>S. boulardii</italic> was performed and the percentage of survival against time was plotted to estimate the UV exposure time required to kill 90% of cells (<xref ref-type="fig" rid="F0001">Figure 1</xref>). An exposure time of 23 <italic>s</italic> was chosen for mutagenesis.</p>
				<fig id="F0001">
					<label>Figure 1</label>
					<caption>
						<p>Survival rate of <italic>S.boulardii</italic> following UV irradiation. Cell counts were performed in triplicates</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-5-29-g001.tif" alt-version="no"/>
				</fig>
			</sec>
			<sec id="S20011">
				<title>Isolation of URA3 mutants</title>
				<p>Mutagenized yeasts were screened for <italic>ura3</italic>
					<sup>
						<italic>-</italic>
					</sup> phenotype on 5-FOA/UU plates. Approximately 350 FOA resistant colonies were isolated and further screened for uracil auxotrophy (<xref ref-type="fig" rid="F0002">Figure 2</xref>). Eight colonies out of 350 were able to grow in YNB-uracil medium but not in YNB. Three mutants, <italic>S. boulardii</italic> M1, M2 and M3, which had similar growth properties compared to the wild type, were chosen for further studies. These mutants were tested for mutation reversion by plating of 10<sup>6</sup>, 10<sup>7</sup> and 10<sup>8</sup> viable cells on YNB agar and counting the number of possible revertants up to 5 days. No revertant was appeared during these incubation periods, indicating that a stable mutation has occurred in the target gene.</p>
				<fig id="F0002">
					<label>Figure 2</label>
					<caption>
						<p>FOA resistant colonies on YNB plates. Approximately 10<sup>7</sup> mutagenized cells (10% survival) were plated on YNB-FOA -UU plates. The resistant colonies appeared after 5-7 days</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-5-29-g002.tif" alt-version="no"/>
				</fig>
			</sec>
			<sec id="S20012">
				<title>Complementation of ura3<sup>-</sup> mutants of S. boulardii</title>
				<p>The URA3 gene from <italic>S. boulardii</italic> was successfully amplified as a 1.2 <italic>kb</italic> fragment using designed specific primers (<xref ref-type="fig" rid="F0003">Figure 3</xref>). This was subsequently cloned into pGEM-Teasy vector. The final construct, pGEM-ura3, was confirmed by restriction analysis and sequencing. The size of <italic>URA3</italic> construct was 4.3 <italic>kb</italic> and the digestion map using SacI/NcoI showed two expected fragments as &#x223C;1 <italic>kb</italic> and 3.3 <italic>kb</italic> (<xref ref-type="fig" rid="F0004">Figure 4B</xref>).</p>
				<fig id="F0003">
					<label>Figure 3</label>
					<caption>
						<p>Amplification of <italic>ura3</italic> and actin fragments using genomic DNA of <italic>S. cerevisiae</italic> and <italic>S. boulardii</italic>. M: Size marker, 1: <italic>S. cerevisiae</italic> ura3 fragment (1.2 <italic>kb</italic>), 2: <italic>S. cerevisiae</italic> actin fragment (0.5 <italic>kb</italic>), 3: <italic>S. boulardii</italic> ura3 and 4: <italic>S. boulardii</italic> actin fragments</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-5-29-g003.tif" alt-version="no"/>
				</fig>
				<fig id="F0004">
					<label>Figure 4</label>
					<caption>
						<p>A) Schematic representation of pGEM-ura3 construct. The position of designed primers and restriction sites is shown. B) Restriction analysis of pGEM-ura3 vector. Lane 1: Fragments generated by <italic>NcoI/SacI</italic> digestion of the construct (&#x223C;1 <italic>kb</italic> and &#x223C;3.3 <italic>kb</italic>). Lane 2: <italic>NcoI</italic> linearized plasmid</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-5-29-g004.tif" alt-version="no"/>
				</fig>
				<p>The potential <italic>ura3</italic>
					<sup>
						<italic>-</italic>
					</sup> mutants of <italic>S. boulardii</italic> (M1, M2 and M3) were transformed with pGEM-ura3 vector. As a positive control, the same mutants were transformed with an episomal vector, pYES2, containing <italic>URA3</italic> as a selectable marker (<xref ref-type="fig" rid="F0005">Figure 5A</xref>). Both transformations were efficient and resulted in several hundred transformants from each single reaction (1 <italic>&#x00B5;g</italic> of each plasmid per reaction).</p>
				<fig id="F0005">
					<label>Figure 5</label>
					<caption>
						<p>A) Schematic representation of pYES2 vector. pYES2 contains the auxotrophic marker <italic>URA3</italic>, 2 <italic>&#x00B5;</italic> origin and the ampicilin resistance marker. B) Restriction analysis of pYES2. Lane 1: undigested plasmid. Lane2: <italic>EcoRI/ClaI</italic> digested vector showed two expected bands of &#x223C;2.5 and &#x223C;3.2 <italic>kb</italic>. Lane 3: <italic>ClaI</italic> linearized plasmid (5.9 <italic>kb</italic>)</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-5-29-g005.tif" alt-version="no"/>
				</fig>
				<p>To confirm that the pYES2 construct is present in these <italic>ura3+</italic>transformants, plasmid DNA was extracted from one of these transformants and subjected to restriction analysis using EcoRI and ClaI Enzymes. The results confirmed that the isolated plasmid is intact and identical to original plasmid, pYES2 (<xref ref-type="fig" rid="F0005">Figure 5B</xref>).</p>
			</sec>
			<sec id="S20013">
				<title>Acid and bile resistance in auxotroph mutants</title>
				<p>The ability of auxotroph mutants to resist pH = 2.5 and 0.3% oxgall was assessed. <xref ref-type="table" rid="T0003">Table 3</xref> shows the growth phenotype of three different mutants compared to the wild types. All tested strains showed different resistance against acid and bile. Among the mutants, only <italic>S. boulardii</italic> M2 showed a resistance pattern similar to the <italic>S. boulardii</italic> wild type.</p>
			</sec>
		</sec>
		<sec id="S0014" sec-type="discussion">
			<title>Discussion</title>
			<p>The design, creation and genetic manipulation of probiotic strains exclusively as vaccine and drug delivery vehicles are promising and rapidly growing area of research (<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0015">15</xref>).</p>
			<p>The yeast <italic>S. boulardii</italic> can be considered as a candidate probiotic for future engineering. To facilitate the genetic manipulation of this yeast, we used the classical UV mutagenesis to produce uacil auxotroph mutants of <italic>S. boulardii</italic> as a host for recombinant protein production. The UV dose-response curve demonstrated a 90% killing rate after 23 <italic>s</italic> of UV irradiation. This result is in agreement with the time range reported by Hashimoto <italic>et al</italic> (20-40S) (<xref ref-type="bibr" rid="CIT0007">7</xref>).</p>
			<p>Ura3<sup>-</sup> mutants were selected on 5-FOA plates. 5-FOA is toxic to yeast cells that can synthesize the ura3 gene product, and therefor makes them unable to grow on 5-FOA-containing media (<xref ref-type="bibr" rid="CIT0011">11</xref>). In addition to act as a positive selection marker, the <italic>URA3</italic> gene can also be used for the negative selection (counter selection). In this regard, the presence of <italic>URA3</italic> confers sensitivity to FOA, while <italic>ura3</italic>
				<sup>-</sup>negative cells are FOA resistant. This concept has been used in designing the ura-blaster gene constructs as a tool in multiple gene disruption experiments in <italic>S. cerevisiae</italic> (<xref ref-type="bibr" rid="CIT0016">16</xref>). Hence, the generation of uracil auxotrophs of <italic>S. boulardii</italic> provides an opportunity for gene deletion studies in this organism.</p>
			<p>To complement the ura3<sup>-</sup> phenotype, the <italic>URA3</italic> gene was amplified from the <italic>S. boulardii</italic> genome and cloned into pGEM-Teasy vector. The restriction analysis of the <italic>URA3</italic> fragment from <italic>S. boulardii</italic> showed a pattern identical to its homologue in <italic>S. cerevisiae</italic>. This pattern was expected as the analysis of sequence data from different strains of <italic>S. boulardii</italic> had confirmed a high similarity between <italic>S. boulardii</italic> and <italic>S. cerevisiae</italic> in DNA level (<xref ref-type="bibr" rid="CIT0017">17</xref>).</p>
			<p>Bile and acid resistance are the most important prerequisites for probiotics to stay alive in the digestive tract of their hosts. Among the three isolated ura3<sup>-</sup> mutants, only one (<italic>S. boulardi</italic> M2) showed acceptable resistance to acid and bile. Similarly, Sharaf <italic>et al</italic>. have used EMS mutagenesis and interspecific protoplast fusion to isolate improved probiotic yeasts. They isolated an adenine auxotroph mutant of <italic>S. boulardii</italic> with high tolerance to bile salt (<xref ref-type="bibr" rid="CIT0018">18</xref>). Abosereh <italic>et al</italic> have also isolated highly resistant <italic>S. boulardii</italic> strains through protoplast fusion (<xref ref-type="bibr" rid="CIT0019">19</xref>). The acid and bile resitance capability of mutants provide these strains with an advantage <italic>in vivo</italic>. Further <italic>in vivo</italic> studies are underway to evaluate other probiotic features of the mutant.</p>
		</sec>
		<sec id="S0015" sec-type="conclusion">
			<title>Conclusion</title>
			<p>A uracil auxotroph mutant of the probiotic yeast, <italic>S. boulardii</italic>, was generated in this study. The mutant was complemented by <italic>URA3</italic> carrying constructs, confirming the inactivation of this gene in the mutant. Bile and acid resistance of the mutant was the same as wild type strain. This mutant can be used as a probiotic host for the <italic>in vivo</italic> production and delivery of various recombinant products to the GI tract.</p>
		</sec>
	</body>
	<back>
		<ack>
			<title>Acknowledgement</title>
			<p>This study was financially supported by a grant awarded to A. Misaghi. All scientific experiments were carried out in VK lab at Pasteur Institute of Iran.</p>
		</ack>
		<ref-list>
			<title>References</title>
			<ref id="CIT0001">
				<label>1</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>D&#x0027;Silva</surname>
							<given-names>I</given-names>
						</name>
					</person-group>
					<article-title>Recombinant technology and probiotics</article-title>
					<source>Int J Eng Technol</source>
					<year>2011</year>
					<volume>3</volume>
					<issue>4</issue>
					<fpage>288</fpage>
					<lpage>293</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0002">
				<label>2</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gaon</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Garcia</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Winter</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Rodriguez</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Quintas</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Gonzalez</surname>
							<given-names>SN</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children</article-title>
					<source>Medicina</source>
					<year>2003</year>
					<volume>63</volume>
					<issue>4</issue>
					<fpage>293</fpage>
					<lpage>298</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0003">
				<label>3</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hebuterne</surname>
							<given-names>X</given-names>
						</name>
					</person-group>
					<article-title>Gut changes attributed to ageing: effects on intestinal microflora. Current opinion in clinical nutrition and metabolic care</article-title>
					<source>Curr Opin Clin Nutr Metab Care</source>
					<year>2003</year>
					<volume>6</volume>
					<issue>1</issue>
					<fpage>49</fpage>
					<lpage>54</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0004">
				<label>4</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Buts</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Digestive diseases and sciences</article-title>
					<source>Dig Dis Sci</source>
					<year>2009</year>
					<volume>54</volume>
					<issue>1</issue>
					<fpage>15</fpage>
					<lpage>18</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0005">
				<label>5</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Riaz</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Alam</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Malik</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Ali</surname>
							<given-names>SM</given-names>
						</name>
					</person-group>
					<article-title>Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: A double blind randomised controlled trial</article-title>
					<source>Indian J Pediatr</source>
					<year>2012</year>
					<volume>79</volume>
					<issue>4</issue>
					<fpage>478</fpage>
					<lpage>482</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0006">
				<label>6</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Czerucka</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Piche</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Rampal</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Review article: yeast as probiotics -- Saccharomyces boulardii</article-title>
					<source>Aliment Pharmacol Ther</source>
					<year>2007</year>
					<volume>26</volume>
					<issue>6</issue>
					<fpage>767</fpage>
					<lpage>778</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0007">
				<label>7</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hashimoto</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Ogura</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Aritomi</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Hoshida</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Ni-shizawa</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Akada</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Isolation of auxotrophic mutants of diploid industrial yeast strains after UV mutagenesis</article-title>
					<source>Appl Environ Microbiol</source>
					<year>2005</year>
					<volume>71</volume>
					<issue>1</issue>
					<fpage>312</fpage>
					<lpage>319</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0008">
				<label>8</label>
				<nlm-citation citation-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Nayak</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<person-group person-group-type="editor">
						<name>
							<surname>Liong</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Biology of eukaryotic probiotics</article-title>
					<source>Probiotics</source>
					<year>2011</year>
					<publisher-loc>Berlin, Heidelberg</publisher-loc>
					<publisher-name>Springer-Verlag</publisher-name>
					<fpage>29</fpage>
					<lpage>54</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0009">
				<label>9</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Pronk</surname>
							<given-names>JT</given-names>
						</name>
					</person-group>
					<article-title>Auxotrophic yeast strains in fundamental and applied research</article-title>
					<source>Appl Environ Microbiol</source>
					<year>2002</year>
					<volume>68</volume>
					<issue>5</issue>
					<fpage>2095</fpage>
					<lpage>2100</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0010">
				<label>10</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Umezu</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Amaya</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Yoshimoto</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Tomita</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<article-title>Purification and properties of orotidine-5&#x2019;-phosphate pyrophosphorylase and orotidine-5&#x2019;-phosphate de-carboxylase from baker&#x0027;s yeast</article-title>
					<source>J Biochem</source>
					<year>1971</year>
					<volume>70</volume>
					<issue>2</issue>
					<fpage>249</fpage>
					<lpage>262</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0011">
				<label>11</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Boeke</surname>
							<given-names>JD</given-names>
						</name>
						<name>
							<surname>LaCroute</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Fink</surname>
							<given-names>GR</given-names>
						</name>
					</person-group>
					<article-title>A positive selection for mutants lacking orotidine-5&#x2019; phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance</article-title>
					<source>Mol Gen Genet</source>
					<year>1984</year>
					<volume>197</volume>
					<issue>2</issue>
					<fpage>345</fpage>
					<lpage>346</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0012">
				<label>12</label>
				<nlm-citation citation-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Peter</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<person-group person-group-type="editor">
						<name>
							<surname>Evans</surname>
							<given-names>I</given-names>
						</name>
					</person-group>
					<article-title>Isolation of yeast DNA</article-title>
					<source>Yeast protocols: Methods in cell and molecular biology</source>
					<year>1996</year>
					<publisher-loc>Totowa</publisher-loc>
					<publisher-name>Humana Press Inc</publisher-name>
					<fpage>103</fpage>
					<lpage>107</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0013">
				<label>13</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Benatuil</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Perez</surname>
							<given-names>JM</given-names>
						</name>
						<name>
							<surname>Belk</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Hsieh</surname>
							<given-names>CM</given-names>
						</name>
					</person-group>
					<article-title>An improved yeast transformation method for the generation of very large human antibody libraries</article-title>
					<source>Pro-tein Eng Des Sel</source>
					<year>2010</year>
					<volume>23</volume>
					<issue>4</issue>
					<fpage>155</fpage>
					<lpage>159</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0014">
				<label>14</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>van der Aa Kuhle</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Skovgaard</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Jespersen</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains</article-title>
					<source>Int J Food Mi-crobiol</source>
					<year>2005</year>
					<volume>101</volume>
					<issue>1</issue>
					<fpage>29</fpage>
					<lpage>39</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0015">
				<label>15</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sleator</surname>
							<given-names>RD</given-names>
						</name>
						<name>
							<surname>Hill</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Patho-biotechnology: using bad bugs to do good things</article-title>
					<source>Curr Opin Biotechnol</source>
					<year>2006</year>
					<volume>17</volume>
					<issue>2</issue>
					<fpage>211</fpage>
					<lpage>216</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0016">
				<label>16</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Alani</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Cao</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Kleckner</surname>
							<given-names>N</given-names>
						</name>
					</person-group>
					<article-title>A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains</article-title>
					<source>Genetics</source>
					<year>1987</year>
					<month>Aug</month>
					<volume>116</volume>
					<issue>4</issue>
					<fpage>541</fpage>
					<lpage>545</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0017">
				<label>17</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>van der Aa Kuhle</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Jespersen</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene</article-title>
					<source>Syst Appl Microbiol</source>
					<year>2003</year>
					<volume>26</volume>
					<issue>4</issue>
					<fpage>564</fpage>
					<lpage>571</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0018">
				<label>18</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sharaf</surname>
							<given-names>AN</given-names>
						</name>
						<name>
							<surname>Abosereh</surname>
							<given-names>NAR</given-names>
						</name>
						<name>
							<surname>Abdalla</surname>
							<given-names>SM</given-names>
						</name>
						<name>
							<surname>Moham-med</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Salim</surname>
							<given-names>RGS</given-names>
						</name>
					</person-group>
					<article-title>Impact of some genetic treatments on the probiotic activities of Saccharomyces boulardii</article-title>
					<source>Res J Cell Mol Biol</source>
					<year>2009</year>
					<volume>3</volume>
					<issue>1</issue>
					<fpage>12</fpage>
					<lpage>19</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0019">
				<label>19</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Abosereh</surname>
							<given-names>NA</given-names>
						</name>
						<name>
							<surname>Mohamed</surname>
							<given-names>HALA</given-names>
						</name>
						<name>
							<surname>ABA ElChalk</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Genetic construction of potentially probiotic Saccharomyces boulardii yeast strains using intraspecific protoplast fusion</article-title>
					<source>J Appl Sci</source>
					<year>2007</year>
					<volume>3</volume>
					<issue>3</issue>
					<fpage>209</fpage>
					<lpage>217</lpage>
				</nlm-citation>
			</ref>
		</ref-list>
	</back>
</article>
